Drug
Ivac W Bre1 Uid
Ivac W Bre1 Uid: highest development phase Phase 1, developed by BioNTech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioNTech
Trials
| Drug | Phase | Indication |
|---|---|---|
| IVAC_W_bre1_uID NCT02316457 | Phase 1 | Breast Cancer (Triple Negative Breast Cancer (TNBC)) |
Latest
No recent events.
Follow Ivac W Bre1 Uid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.